SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9%

Pajjiż: Singapor

Lingwa: Ingliż

Sors: HSA (Health Sciences Authority)

Ingredjent attiv:

SODIUM CHLORIDE

Disponibbli minn:

BAXTER HEALTHCARE (ASIA) PTE LTD

Kodiċi ATC:

B05XA03

Dożaġġ:

450 mg/50 ml

Għamla farmaċewtika:

INJECTION

Kompożizzjoni:

SODIUM CHLORIDE 450 mg/50 ml

Rotta amministrattiva:

INTRAVENOUS

Tip ta 'preskrizzjoni:

General Sale List

Manifatturat minn:

BAXTER HEALTHCARE PTY LTD

L-istatus ta 'awtorizzazzjoni:

ACTIVE

Data ta 'l-awtorizzazzjoni:

1998-01-09

Karatteristiċi tal-prodott

BAXTER SODIUM CHLORIDE
INTRAVENOUS INFUSION 0.9%
1 NAME OF THE MEDICINE
Sodium chloride
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Baxter Sodium Chloride Intravenous (IV) Infusion preparations are
sterile, non-pyrogenic
solutions of sodium chloride in Water for Injections. The preparations
do not contain an
antimicrobial agent or added buffer, and have a pH of 4.0 – 7.0.
Baxter Sodium Chloride 0.9% IV Infusion is isotonic. The concentration
of sodium chloride in
each preparation and their osmolarities are shown in Table 1 (see
section 6.5 Nature and
Contents of Container).
For the full list of excipients, see Section 6.1 List of Excipients.
3 PHARMACEUTICAL FORM
Solution for Intravenous Infusion.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
Baxter Sodium Chloride 0.9% IV Infusion is indicated for extracellular
fluid replacement and
in the management of metabolic alkalosis in the presence of fluid
loss, and for restoring or
maintaining the concentration of sodium and chloride ions.
4.2 DOSE AND METHOD OF ADMINISTRATION
GENERAL DIRECTIVE
Baxter Sodium Chloride IV Infusion is for intravenous infusion.
To be used as directed by the doctor.
Dosage, rate, and duration of administration are to be individualised
and depend upon the
indication for use, the patient’s age, weight, clinical condition,
and concomitant treatment, and
on the patient’s clinical and laboratory response to treatment.
Parenteral drug products should be inspected visually for particulate
matter and discolouration
prior to administration whenever solution and container permit. The
solution should be clear and
free from particles. Do not administer unless solution is clear and
seal is intact.
Additives may be incompatible. Suitability of potential additives has
not been demonstrated.
Complete information is not available. Those additives known to be
incompatible should not be
used. Before adding a substance or medication, verify that it is
soluble and/or stable in water and
that the pH range of Baxter Sodium Chloride IV Infusion is
appropr